No results for ‘’
Shukra Pharmaceuticals Ltd
NSE: BSE: 524632
₹30.98
(2.79%)
Mon, 15 Jun 2026, 07:06 am
Market Cap (in Cr)1395.52
PE Ratio61.60
Dividend0.03
Health Technology
Pharmaceuticals: Major
24.5KShukra Pharmaceuticals Cashflow
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Deprecation and amortization | -14.74M | -16.62M | -18.38M | -20.50M | -30.05M |
| Accumulated depreciation, total | -158.34M | -174.97M | -193.35M | -213.84M | -240.28M |
| Cash from operating activities | 5.84M | 75.34M | 29.78M | -49.23M | 88.03M |
| Funds from operations | 15.84M | 22.43M | 56.02M | 210.82M | 125.80M |
| Net income (cash flow) | 1.88M | 7.51M | 44.06M | 185.37M | 95.75M |
| Depreciation & amortization (cash flow) | 14.74M | 16.62M | 18.38M | 20.50M | 30.05M |
| Depreciation/depletion | 14.74M | 16.62M | 18.38M | 20.50M | 30.05M |
| Amortization | — | — | — | — | — |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 130.00K | -4.37M | -6.77M | -8.51M | -37.62M |
| Changes in working capital | -10.00M | 52.91M | -26.24M | -260.05M | -37.77M |
| Cash from investing activities | -19.41M | -15.59M | -44.91M | -17.60M | -27.43M |
| Capital expenditures | -17.91M | -15.50M | -44.91M | -17.60M | -27.43M |
| Capital expenditures - fixed assets | -17.91M | -15.50M | -44.91M | -17.60M | -27.43M |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | 0 |
| Cash from financing activities | 17.36M | -63.94M | 51.97M | 126.90M | -39.23M |
| Free cash flow | -12.07M | 59.84M | -15.13M | -66.83M | 60.60M |